07/24/2024 | Press release | Distributed by Public on 07/24/2024 14:17
Item 5.07 Submission of Matters to a Vote of Security Holders.
The following matters were submitted to a vote of common shareholders at the 2023 annual meeting of stockholders of SunLink Health Systems, Inc. (the "Company") held on June 28, 2024:
Election of Directors
Management's nominees for election to the board of directors, as listed in the Company's proxy statement, were elected for two-year terms; with the results of the voting as follows:
Nominee |
For |
Withheld |
Against |
Broker |
||||||||||||
Robert M. Thornton, Jr. |
2,568,294 |
831,391 |
0 |
1,250,813 |
||||||||||||
Dr. Steven J. Baileys, Jr. |
2,692,389 |
707,296 |
0 |
1,250,813 |
||||||||||||
Gene E, Burleson |
2,599,505 |
800,180 |
0 |
1,250,813 |
||||||||||||
As indicated in the table above, Robert M. Thornton, Jr, Dr. Steven, J. Baileys. Jr. and Gene E. Burleson were elected as directors for terms expiring at the 2025 annual meeting of shareholders. The terms of the following incumbent directors continue until the 2024 annual meeting of shareholders: C, Michael Ford and Mark J. Stockslager.
Management also proposed the ratification of the appointment of the Company's independent auditors for the 2023 fiscal year. The table below summarizes the results of the voting on these proposals by the Company's stockholders:
For Against Abstentions
4,155,670 88,767 84,193
Ratification of the appointment of Cherry Bekaert LLP as the Company's Independent Registered Public Accounting Firm.
As indicated in the above table table, the proposal to ratify the appointment of the Company's independent auditors for the 2023 fiscal year was approved.
Management also proposed: (i) a non-binding advisory vote on executive compensation, (ii) a non-binding advisory vote on the frequency of the vote on executive compensation. The table below summarizes the results of the voting on these proposals by the Company's stockholders:
Approval of a non-binding advisory resolution relating to the compensation of the Company's Named Executive Officers.
For |
Against |
Abstentions |
Broker Non-votes |
|||
2,762,502 |
433,424 |
203,759 |
1,250,813 |
As indicated in the above table, the proposal to approve executive compensation was approved.
Approval of a non-binding advisory resolution on the frequency (every one, two or three years) of the non-binding vote to approve the compensation of the Company's Named Executive Officers.
Every Year |
Every Two Years |
Every Three Years |
Abstentions |
|||
1,683,695 |
4,237 |
1,704,447 |
7,306 |
|||
As indicated in the above table, the proposal was approved to hold such advisory vote every three-years.